Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about AMI: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
AMI is a concept in neurodegeneration research. Key relationships include: implicated in, associated with. Connected to 113 entities in the SciDEX knowledge graph.
No AI portrait yet
graph TD
AMI["AMI"]
MAP1B["MAP1B"] -->|"implicated in"| AMI
MAP2["MAP2"] -->|"implicated in"| AMI
MAP6["MAP6"] -->|"implicated in"| AMI
RAB7A["RAB7A"] -->|"implicated in"| AMI
LRP2["LRP2"] -->|"implicated in"| AMI
ACTB["ACTB"] -->|"implicated in"| AMI
CTSD["CTSD"] -->|"implicated in"| AMI
ATG["ATG"] -->|"implicated in"| AMI
EGFR["EGFR"] -->|"implicated in"| AMI
SREBF1["SREBF1"] -->|"implicated in"| AMI| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| MMP9 | associated_with | protein | 0.72 |
| 41484454 | has neuroprotective effects through | paper | 0.60 |
| CYP2E1 | implicated_in | gene | 0.50 |
| IDH2 | implicated_in | gene | 0.50 |
| IDH1 | implicated_in | gene | 0.50 |
| MAP1B | implicated_in | gene | 0.50 |
| MAP2 | implicated_in | gene | 0.50 |
| MAP6 | implicated_in | gene | 0.50 |
| RAB7A | implicated_in | gene | 0.50 |
| LRP2 | implicated_in | gene | 0.50 |
| ACTB | implicated_in | gene | 0.50 |
| CTSD | implicated_in | gene | 0.50 |
| ATG | implicated_in | gene | 0.50 |
| EGFR | implicated_in | gene | 0.50 |
| SREBF1 | implicated_in | gene | 0.50 |
| NADH | implicated_in | gene | 0.50 |
| MTORC1 | implicated_in | gene | 0.50 |
| PPARG | implicated_in | gene | 0.50 |
| RPS6KB1 | implicated_in | gene | 0.50 |
| PPARA | implicated_in | gene | 0.50 |
| LAMP1 | implicated_in | gene | 0.50 |
| RUBCN | implicated_in | gene | 0.50 |
| MTOR | implicated_in | gene | 0.50 |
| RAS | implicated_in | gene | 0.50 |
| RPS6 | implicated_in | gene | 0.50 |
| PIK3C3 | implicated_in | gene | 0.50 |
| ATP | implicated_in | gene | 0.50 |
| SQSTM1 | implicated_in | gene | 0.50 |
| CAT | implicated_in | gene | 0.50 |
| PPAR | implicated_in | gene | 0.50 |
| ROS | implicated_in | gene | 0.50 |
| BACE1 | implicated_in | gene | 0.50 |
| LIS1 | implicated_in | gene | 0.50 |
| DCX | implicated_in | gene | 0.50 |
| RELN | implicated_in | gene | 0.50 |
| APOE | implicated_in | gene | 0.50 |
| HCN1 | implicated_in | gene | 0.50 |
| HCN4 | implicated_in | gene | 0.50 |
| HCN2 | implicated_in | gene | 0.50 |
| SLC16A2 | implicated_in | gene | 0.50 |
| SLC16A1 | implicated_in | gene | 0.50 |
| VEGFA | implicated_in | gene | 0.50 |
| EEF1A1 | implicated_in | gene | 0.50 |
| APOB | implicated_in | gene | 0.50 |
| MET | implicated_in | gene | 0.50 |
| MCL1 | implicated_in | gene | 0.50 |
| SF3B1 | implicated_in | gene | 0.50 |
| SMARCA4 | implicated_in | gene | 0.50 |
| DNA | implicated_in | gene | 0.50 |
| LZTR1 | implicated_in | gene | 0.50 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Plasma ATN biomarkers across AD continuum in Chilean cohort | clinical | Alzheimer's disease | 0.950 | 0.00 | Chilean older adults (n=318) w | proposed | N/A |
| Autophagy receptor identification for stress granule elimination | exploratory | neurodegenerative diseases | 0.900 | 0.00 | cultured cells under arsenite | proposed | N/A |
| Epigenetic clocks association with brain aging patterns in older women | exploratory | cognitive impairment and demen | 0.900 | 0.00 | human patients | proposed | N/A |
| Tau depletion effects on neuronal development in primary cultures | exploratory | 0.900 | 0.00 | primary rodent neuronal cultur | proposed | N/A | |
| Differential GWAS of schizophrenia vs PTSD | exploratory | schizophrenia, post-traumatic | 0.900 | 0.00 | human patients - European ance | proposed | N/A |
| Tau depletion effects on neuronal development in primary cultures | exploratory | 0.900 | 0.00 | primary rodent neuronal cultur | proposed | N/A | |
| Creation and validation of 3xAD-ChAT-Cre mouse model | validation | Alzheimer's disease | 0.900 | 0.00 | 3xAD-ChAT-Cre transgenic mice | proposed | N/A |
| GTEx brain tissue expression analysis of MAPT/CRHR1 locus | exploratory | schizophrenia, post-traumatic | 0.850 | 0.00 | human brain tissue samples fro | proposed | N/A |
| Microtubule domain analysis in adult axons | exploratory | 0.800 | 0.00 | adult rodent axons | proposed | N/A | |
| Tau depletion effects on microtubule domains in adult axons | exploratory | 0.800 | 0.00 | adult rodent neurons | proposed | N/A | |
| Sequential DFO + Sulforaphane Prevents Iron-Ferroptosis Cascade in Rat | in_vivo | post-cardiac-arrest neurodegen | 0.768 | 0.72 | Sprague-Dawley rat asphyxial c | proposed | $48,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Pathogenic Variants and Olipudase Alfa Treatment of Patients With Acid Sphingomy [PMID:41692468] | ["Hsu-Heng Lin", "Hui-An Chen", "Shyh-Je | Molecular genetics & genom | 2026 | 0 |
| Multi-omics analysis identifies SMPD1 as a key contributor in sphingolipid pathw [PMID:41428198] | ["Aron Park", "Baeki E Kang", "Eun-Ju Ji | Genes & genomics | 2026 | 0 |
| Mammalian lipophagy: process and function. [PMID:41681129] | Zhao R, Dai E, Kang R, Liu J, Klionsky D | Autophagy | 2026 | 0 |
| A multi-dimensional bioinformatic dissection of the molecular mechanisms in high [PMID:41191606] | Yu X MD, Lei J MSc, Du X MSc, He Y MSc, | Int J Surg | 2026 | 0 |
| Plasma metabolites may inhibit childhood obesity by regulating ferroptosis throu [PMID:41249848] | Wang JG, Pan XH, Li Y | Int J Obes (Lond) | 2026 | 0 |
| Multi-omics analysis identifies SMPD1 as a key contributor in sphingolipid pathw [PMID:41428198] | Park A, Kang BE, Jin EJ, Kim HJ, Lee CW | Genes Genomics | 2026 | 0 |
| AXL Promotes Ischemic Myelin Repair Through Alleviating Myelin Debris Deposition [PMID:41524160] | Jia J, Gan Y, Li J, Li L, Meng H et al. | Adv Sci (Weinh) | 2026 | 0 |
| Pathogenic Variants and Olipudase Alfa Treatment of Patients With Acid Sphingomy [PMID:41692468] | Lin HH, Chen HA, Lin SJ, Hsu RH, Lee NC | Mol Genet Genomic Med | 2026 | 0 |
| AXL Promotes Ischemic Myelin Repair Through Alleviating Myelin Debris Deposition [PMID:41524160] | Jia J, Gan Y, Li J, Li L, Meng H, Sun M, | Advanced science (Weinheim, Ba | 2026 | 0 |
| A multi-dimensional bioinformatic dissection of the molecular mechanisms in high [PMID:41191606] | Yu X, Lei J, Du X, He Y, Peng W, Yang R, | International journal of surge | 2026 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Current View on PPAR-α and Its Relation to Neurosteroids in Alzheimer's Di [PMID:39000217] | Unknown | International journal of molec | 2024 | 0 |
| Neurodegeneration and demyelination in multiple sclerosis. [PMID:38889714] | Garton T, Gadani SP, Gill AJ, Calabresi | Neuron | 2024 | 0 |
| STING orchestrates the neuronal inflammatory stress response in multiple scleros [PMID:38878778] | Woo MS, Mayer C, Binkle-Ladisch L, Sonne | Cell | 2024 | 0 |
| Gasdermin-E mediates mitochondrial damage in axons and neurodegeneration. [PMID:36917977] | Neel DV, Basu H, Gunner G, Bergstresser | Neuron | 2023 | 0 |
| Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] | Marogianni C, Sokratous M, Dardiotis E, | International journal of molec | 2020 | 0 |
| Pyrethroid exposure and neurotoxicity: a mechanistic approach. [PMID:31246571] | Unknown | Arhiv za higijenu rada i toksi | 2020 | 0 |
| Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] | Marogianni C, Sokratous M, Dardiotis E, | International journal of molec | 2020 | 0 |
| Multiple Sclerosis Pathology. [PMID:29358320] | Lassmann H | Cold Spring Harbor perspective | 2018 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning AMI in their description or question text
Score: 0.740 · neuroscience · 2026-04-07
## Mechanistic Overview Dopaminergic Ventral Tegmental-Hippocampal Circuit Protection starts from the claim that modulat
Score: 0.732 · neurodegeneration · 2026-04-16
**Molecular Mechanism and Rationale** The molecular foundation for SMPD1 inhibition in Alzheimer's disease centers on t
Score: 0.710 · neuroscience · 2026-04-26
FRAP-based measurement of TDP-43 liquid-liquid phase separation state provides a continuous biomarker of nuclear-cytopla
Score: 0.700 · neurodegeneration · 2026-04-22
## Mechanistic Overview Ataxin-2 Polyglutamine Expansions Hijack G3BP1 to Form Toxic, Irreversible Stress Granule Comple
Score: 0.686 · neurodegeneration · 2026-04-02
## Mechanistic Overview Lysosomal Positioning Dynamics Modulation starts from the claim that modulating LAMP1 within the
Score: 0.680 · neurodegeneration · 2026-04-22
## **Molecular Mechanism and Rationale** The proposed mechanism centers on a complex interplay between gut microbiota,
Score: 0.677 · translational neuroscience · 2026-04-16
## Mechanistic Overview Dynamic Lactate-Pyruvate Ratio as Therapeutic Stratification Biomarker starts from the claim tha
Score: 0.666 · neurodegeneration · 2026-04-02
## Mechanistic Overview Lipid Droplet Dynamics as Phenotype Switches starts from the claim that modulating DGAT1 and SOA
Score: 0.639 · neurodegeneration · 2026-04-02
Transglutaminase-2 creates covalent cross-links between lysine and glutamine residues shared across tau, α-synuclein, an
Score: 0.618 · neurodegeneration · 2026-04-13
## Mechanistic Overview BH4 Cofactor Restoration as Primary Driver of >500-Fold Dopamine Elevation starts from the claim
Score: 0.606 · neurodegeneration · 2026-04-02
## Mechanistic Overview Correcting Gut Microbial Dopamine Imbalance to Support Systemic Dopaminergic Function starts fro
Score: 0.597 · neurodegeneration · 2026-04-02
Heparan sulfate and other glycosaminoglycans serve as nucleation templates that facilitate cross-seeding by concentratin
Score: 0.577 · neurodegeneration · 2026-04-20
**Molecular Mechanism and Rationale** The molecular foundation of this biomarker panel centers on the intricate interpl
Score: 0.532 · translational neuroscience · 2026-04-12
## Mechanistic Overview Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammation-Metabolism Interface Biomarker sta